4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online
13220
Practical Factors Influencing the Use of Confirmatory Blood-Based Biomarkers in Alzheimer’s Care
Poster Presenter
Authors
James E. Galvin, Leah Zullig, Alison B. Allen, Ryan S. Drake, Douglas Galasko, Soeren Mattke, Michelle M. Mielke, Marwan Noel Sabbagh, Nicholas J. Giordano, Courtney Adams, Feride Frech, Kimberly Petro, Daryl Rhys Jones
Affiliations
Barrow Neurological Institute, Phoenix, AZ, USA, Eisai Inc., Nutley, NJ, USA, Roaring Fork Neurology, Basalt, CO, USA, NeuroCare Center, Inc., Canton, OH, USA, University of Miami Miller School of Medicine, Miami, FL, USA, Duke University School of Medicine, Durham, NC, USA, University of California San Diego, San Diego, CA, USA, University of Southern California, Los Angeles, CA, USA, Wake Forest University School of Medicine, Winston-Salem, NC, USA, Premier Applied Sciences, Premier, Inc., Charlotte, NC, USA
Part of Topic
Biomarkers -> Biomarkers (non-neuroimaging) -> Fluid biomarkers
Summary
Confirmatory blood-based biomarkers (BBMs) for Alzheimer's disease were feasible across diverse clinical settings, with same-day testing and structured workflows supporting adoption. Implementation barriers were primarily operational, including reimbursement, logistics, and workflow integration challenges.
Keywords: Blood-based biomarkers (BBMs); Implementation; Clinical workflows; Reimbursement; Diagnostic pathways; Standardization
Comments
Email is required but is not shown publicly.
Loading comments...